======= UBXN1 ======= == Gene Information == * **Official Symbol**: UBXN1 * **Official Name**: UBX domain protein 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=51035|51035]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q04323|Q04323]] * **Interactions**: [[https://thebiogrid.org/search.php?search=UBXN1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20UBXN1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/616378|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Ubiquitin-binding protein that plays a role in the modulation of innate immune response. Blocks both the RIG-I-like receptors (RLR) and NF-kappa-B pathways. Following viral infection, UBXN1 is induced and recruited to the RLR component MAVS. In turn, interferes with MAVS oligomerization, and disrupts the MAVS/TRAF3/TRAF6 signalosome. This function probably serves as a brake to prevent excessive RLR signaling (PubMed:23545497). Interferes with the TNFalpha-triggered NF-kappa-B pathway by interacting with cellular inhibitors of apoptosis proteins (cIAPs) and thereby inhibiting their recruitment to TNFR1 (PubMed:25681446). Prevents also the activation of NF-kappa-B by associating with CUL1 and thus inhibiting NF-kappa-B inhibitor alpha/NFKBIA degradation that remains bound to NF-kappa-B (PubMed:28152074). Interacts with the BRCA1-BARD1 heterodimer and regulates its activity. Specifically binds 'Lys-6'-linked polyubiquitin chains. Interaction with autoubiquitinated BRCA1 leads to the inhibition of the E3 ubiquitin-protein ligase activity of the BRCA1-BARD1 heterodimer (PubMed:20351172). Component of a complex required to couple deglycosylation and proteasome-mediated degradation of misfolded proteins in the endoplasmic reticulum that are retrotranslocated in the cytosol. {ECO:0000269|PubMed:20351172, ECO:0000269|PubMed:23545497, ECO:0000269|PubMed:25681446, ECO:0000269|PubMed:28152074}. |UBA| |UBX| |proteasome regulatory particle binding| |negative regulation of ubiquitin-specific protease activity| |negative regulation of protein K48-linked deubiquitination| |K6-linked polyubiquitin modification-dependent protein binding| |regulation of protein K48-linked deubiquitination| |negative regulation of protein deubiquitination| |regulation of ubiquitin-specific protease activity| |K48-linked polyubiquitin modification-dependent protein binding| |VCP-NPL4-UFD1 AAA ATPase complex| |regulation of protein deubiquitination| |negative regulation of ERAD pathway| |regulation of ERAD pathway| |polyubiquitin modification-dependent protein binding| |negative regulation of proteasomal ubiquitin-dependent protein catabolic process| |negative regulation of response to endoplasmic reticulum stress| |negative regulation of ubiquitin-dependent protein catabolic process| |negative regulation of proteasomal protein catabolic process| |negative regulation of proteolysis involved in cellular protein catabolic process| |negative regulation of protein ubiquitination| |ATPase binding| |ubiquitin binding| |regulation of response to endoplasmic reticulum stress| |negative regulation of protein modification by small protein conjugation or removal| |negative regulation of cellular protein catabolic process| |regulation of proteasomal ubiquitin-dependent protein catabolic process| |negative regulation of protein catabolic process| |regulation of ubiquitin-dependent protein catabolic process| |regulation of proteasomal protein catabolic process| |regulation of protein ubiquitination| |regulation of proteolysis involved in cellular protein catabolic process| |regulation of protein modification by small protein conjugation or removal| |protein folding| |regulation of cellular protein catabolic process| |negative regulation of cellular catabolic process| |negative regulation of peptidase activity| |ubiquitin protein ligase binding| |negative regulation of catabolic process| |proteasome-mediated ubiquitin-dependent protein catabolic process| |proteasomal protein catabolic process| |negative regulation of proteolysis| |neuronal cell body| |regulation of protein catabolic process| |dendrite| |regulation of peptidase activity| |negative regulation of hydrolase activity| |ubiquitin-dependent protein catabolic process| |modification-dependent protein catabolic process| |modification-dependent macromolecule catabolic process| |proteolysis involved in cellular protein catabolic process| |negative regulation of protein modification process| |cellular protein catabolic process| |protein catabolic process| |viral process| |regulation of proteolysis| |regulation of cellular response to stress| |symbiotic process| |negative regulation of catalytic activity| |interspecies interaction between organisms| |regulation of cellular catabolic process| |cellular macromolecule catabolic process| |regulation of catabolic process| |endoplasmic reticulum| |negative regulation of cellular protein metabolic process| |macromolecule catabolic process| |organonitrogen compound catabolic process| |negative regulation of protein metabolic process| |negative regulation of molecular function| |proteolysis| |regulation of hydrolase activity| |regulation of response to stress| |negative regulation of response to stimulus| |organic substance catabolic process| |cellular catabolic process| |regulation of protein modification process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp468|CB-5083 0.4μM R08 exp468]]|-4.71| |[[:results:exp136|MS094 2μM R03 exp136]]|-2.28| |[[:results:exp293|Myriocin 25μM R06 exp293]]|-2.22| |[[:results:exp531|THZ1 0.06μM R08 exp531]]|-2.08| |[[:results:exp256|HMS-I1 10μM R06 exp256]]|-1.98| |[[:results:exp318|ABT-702 5μM R07 exp318]]|-1.9| |[[:results:exp96|BI-2536 0.02μM R03 exp96]]|-1.86| |[[:results:exp129|Isonicotinamide 500μM R03 exp129]]|-1.86| |[[:results:exp149|SB203580 25μM R03 exp149]]|-1.81| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 5500 * **Expression level (log2 read counts)**: 6.04 {{:chemogenomics:nalm6 dist.png?nolink |}}